Cynthia Collins, CEO at Editas Medicine, Inc. (EDIT), sold 3,952 shares at $36.66 ($145K) on 2020-08-20, disclosed to the SEC on 2020-08-21.
Open-market sale of $145k EDIT by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.66 | 1,976 | $72K | 50.0% |
| 2 | $36.66 | 1,976 | $72K | 50.0% |
| Total | $36.66 avg | 3,952 | $145K | 100% |
| Filing → |
| BEC | SELL | 2009-01-06 | $9K | — | Filing → |